Browse studies

Find your next paid study

1 recruiting study matching your filters

This is a Global, Multi-center, Open-label Randomized and Registrational Phase 3 Study of Olverembatinib (HQP1351) in Patients With Chronic Phase Chronic Myeloid Leukemia

A Global Multicenter, Open Label, Randomized, Phase 3 Registrational Study of Olverembatinib (HQP1351) in Patients with Chronic Phase Chronic Myeloid Leukemia …

Chronic Myeloid LeukemiaCMLCML, Chronic Phase

Ascentage Pharma Group Inc.NCT06423911